1,2-Dichloroethane → ({3-[7-(4-Fluoro-benzyl)-9-hydroxy-5-methoxy-8-oxo-7,8-dihydro-6H-pyrrolo[3,4-g]quinolin-6-ylsulfanyl]-propionylamino}-methyl)-phosphonic Acid Diethyl Ester

HRID 853633ノート

反応式

HRID 853633 の反応式
[F:1][C:2]1[CH:31]=[CH:30][C:5]([CH2:6][N:7]2[C:19](=[O:20])[C:18]3[C:17]([OH:21])=[C:16]4[C:11]([CH:12]=[CH:13][CH:14]=[N:15]4)=[C:10]([O:22][CH3:23])[C:9]=3[CH:8]2[S:24][CH2:25][CH2:26][C:27]([OH:29])=O)=[CH:4][CH:3]=1.C(O)(=O)C(O)=O.[CH2:38]([O:40][P:41]([CH2:46][NH2:47])(=[O:45])[O:42][CH2:43][CH3:44])[CH3:39].C(Cl)CCl.P(=O)([O-])OCN>C(Cl)Cl>[CH2:38]([O:40][P:41]([CH2:46][NH:47][C:27](=[O:29])[CH2:26][CH2:25][S:24][CH:8]1[C:9]2[C:10]([O:22][CH3:23])=[C:11]3[C:16](=[C:17]([OH:21])[C:18]=2[C:19](=[O:20])[N:7]1[CH2:6][C:5]1[CH:30]=[CH:31][C:2]([F:1])=[CH:3][CH:4]=1)[N:15]=[CH:14][CH:13]=[CH:12]3)(=[O:45])[O:42][CH2:43][CH3:44])[CH3:39]

参加物

6

反応物 4

HCID 111,2-Dichloroethane2 回HCID 2733594diethyl (aminomethyl)phosphonate oxalate saltHCID 100034673-[[7-[(4-fluorophenyl)methyl]-9-hydroxy-5-methoxy-8-oxo-6H-pyrrolo[3,4-g]quinolin-6-yl]sulfanyl]propanoic acidHCID 178514127HCID 178514127、化合物

生成物 1

HCID 10483568({3-[7-(4-Fluoro-benzyl)-9-hydroxy-5-methoxy-8-oxo-7,8-dihydro-6H-pyrrolo[3,4-g]quinolin-6-ylsulfanyl]-propionylamino}-methyl)-phosphonic Acid Diethyl Ester

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

To a solution of 24 (15 mg, 0.035 mmol) in 0.35 mL of CH2Cl2 (0.35 mL) was added diethyl(aminomethyl)phosphonate oxalate (27 mg, 0.105 mmol), EDC (20 mg, 0.105 mmol) and TEA (15 μL, 0.105 mmol). The solution was stirred at room temperature for 1 day when the same amount of the aminomethyl phosphonate, EDC and TEA were added. The reaction was stirred for another day when complete conversion of starting materials to the desired product was observed by LCMS. The product 26 was purified by reverse phase HPLC using 5-95% A. Buffer A contained CH3CN-1% HOAc and buffer B was H2O-1% HOAc. 1H NMR (300 MHz, CDCl3) δ 1.33-1.40 (m, 6H), 2.37-2.45 (m, 4H), 3.60-3.72 (m, 2H), 4.05 (s, 3H), 4.06-4.18 (m, 4H), 4.44 (d, 1H, J=15 Hz), 5.33 (d, 1H, J=14 Hz), 5.49 (s, 1H), 6.17 (br s, 1H), 6.98-7.08 (m, 2H), 7.33-7.43 (m, 2H), 7.55-7.63 (m, 1H), 8.50-8.57 (br d, 1H), 8.97 (br s, 1H); 31P (121.4 MHz, CDCl3) δ 22.7; 19F NMR (282.6 MHz, CDCl3) δ 62.6; EI MS (m/z) 590.4 [M−H]−, 614.2 [M+Na].

後処理

  1. additionwere added

出典と根拠

ORDレコード
ord-3f236d19e45146df80ee5ca44c04116c
出典データセット
uspto-grants-2007_08
特許番号
US07253180B2

反応ノート

読み込み中…